Terms: = Germ cell tumor AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Clinical Outcome
149 results:
1. Molecular characteristics and improved survival prediction in a cohort of 2023 ependymomas.
Pohl LC; Leitheiser M; Obrecht D; Schweizer L; Wefers AK; Eckhardt A; Raffeld M; Sturm D; Pajtler KW; Rutkowski S; Fukuoka K; Ichimura K; Bockmayr M; Schüller U
Acta Neuropathol; 2024 Jan; 147(1):24. PubMed ID: 38265522
[TBL] [Abstract] [Full Text] [Related]
2. mycn amplification, TERT rearrangements and ATRX mutations in neuroblastoma: clinicopathological correlates- an Indian perspective.
Kerkar AN; Chinnam D; Verma A; Peters NJ; Kakkar N; Trehan A; Singh M; Gupta K
Virchows Arch; 2023 Oct; 483(4):477-486. PubMed ID: 37460674
[TBL] [Abstract] [Full Text] [Related]
3. Ganglioneuroblastoma intermixed: Clinicopathological implications of diagnosis at presentation and genomic correlations.
Nezami BG; Modak S; Cardenas FI; Sarungbam J; Sirintrapun SJ; Gopalan A; Chen Y; Al-Ahmadie H; Fine SW; Reuter VE; Tickoo SK
Pediatr Blood Cancer; 2023 Aug; 70(8):e30434. PubMed ID: 37243318
[TBL] [Abstract] [Full Text] [Related]
4. High Expression of the Lysosomal Protease Cathepsin D Confers Better Prognosis in Neuroblastoma Patients by Contrasting EGF-Induced Neuroblastoma cell Growth.
Secomandi E; Salwa A; Vidoni C; Ferraresi A; Follo C; Isidoro C
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563171
[TBL] [Abstract] [Full Text] [Related]
5. mycn mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis.
Alborzinia H; Flórez AF; Kreth S; Brückner LM; Yildiz U; Gartlgruber M; Odoni DI; Poschet G; Garbowicz K; Shao C; Klein C; Meier J; Zeisberger P; Nadler-Holly M; Ziehm M; Paul F; Burhenne J; Bell E; Shaikhkarami M; Würth R; Stainczyk SA; Wecht EM; Kreth J; Büttner M; Ishaque N; Schlesner M; Nicke B; Stresemann C; Llamazares-Prada M; Reiling JH; Fischer M; Amit I; Selbach M; Herrmann C; Wölfl S; Henrich KO; Höfer T; Trumpp A; Westermann F
Nat Cancer; 2022 Apr; 3(4):471-485. PubMed ID: 35484422
[TBL] [Abstract] [Full Text] [Related]
6. Updates in the classification of ependymal neoplasms: The 2021 WHO Classification and beyond.
Kresbach C; Neyazi S; Schüller U
Brain Pathol; 2022 Jul; 32(4):e13068. PubMed ID: 35307892
[TBL] [Abstract] [Full Text] [Related]
7. Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With Neuroblastoma.
Verly IRN; Matser YAH; Leen R; Meinsma R; Fiocco M; Koster J; Volckmann R; Savci-Heijink D; Cangemi G; Barco S; Valentijn LJ; Tytgat GAM; van Kuilenburg ABP
JCO Precis Oncol; 2022 Jan; 6():e2000447. PubMed ID: 35085004
[TBL] [Abstract] [Full Text] [Related]
8. Combined Detection of Copy Number Variations of mycn and ALK using Droplet Digital Polymerase Chain Reaction to Identify High-Risk Patients with Neuroblastoma.
Trivedi T; Panchal K; Bhalala N; Trivedi P; Panchal H
World Neurosurg; 2022 Mar; 159():e48-e57. PubMed ID: 34861448
[TBL] [Abstract] [Full Text] [Related]
9. Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma.
Bao R; Spranger S; Hernandez K; Zha Y; Pytel P; Luke JJ; Gajewski TF; Volchenboum SL; Cohn SL; Desai AV
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34272305
[TBL] [Abstract] [Full Text] [Related]
10. Restoration of the molecular clock is tumor suppressive in neuroblastoma.
Moreno-Smith M; Milazzo G; Tao L; Fekry B; Zhu B; Mohammad MA; Di Giacomo S; Borkar R; Reddy KRK; Capasso M; Vasudevan SA; Sumazin P; Hicks J; Putluri N; Perini G; Eckel-Mahan K; Burris TP; Barbieri E
Nat Commun; 2021 Jun; 12(1):4006. PubMed ID: 34183658
[TBL] [Abstract] [Full Text] [Related]
11. FOXR2 Stabilizes mycn Protein and Identifies Non-
Schmitt-Hoffner F; van Rijn S; Toprak UH; Mauermann M; Rosemann F; Heit-Mondrzyk A; Hübner JM; Camgöz A; Hartlieb S; Pfister SM; Henrich KO; Westermann F; Kool M
J Clin Oncol; 2021 Oct; 39(29):3217-3228. PubMed ID: 34110923
[TBL] [Abstract] [Full Text] [Related]
12. Biological features and clinical outcome in infant neuroblastoma: a multicenter experience in Beijing.
Zhang S; Zhang W; Jin M; Sun Q; Zhang Z; Qin H; Su Y; Zhi T; Xie Y; Gao YX; Zhang X; Li L; Liu R; Zhao W; Wang H; Huang D; Ma X
Eur J Pediatr; 2021 Jul; 180(7):2055-2063. PubMed ID: 33580827
[TBL] [Abstract] [Full Text] [Related]
13. Implication of Image-Defined Risk Factors for the Extent of Surgical Resection and clinical outcome in Patients with Pelvic Neuroblastoma.
Froeba-Pohl A; von Schweinitz D; Muehling J; Paolini M; Hubertus J
Eur J Pediatr Surg; 2021 Aug; 31(4):362-366. PubMed ID: 32862422
[TBL] [Abstract] [Full Text] [Related]
14. Suppression of ABCE1-Mediated mRNA Translation Limits n-myc-Driven Cancer Progression.
Gao J; Jung M; Mayoh C; Venkat P; Hannan KM; Fletcher JI; Kamili A; Gifford AJ; Kusnadi EP; Pearson RB; Hannan RD; Haber M; Norris MD; Somers K; Henderson MJ
Cancer Res; 2020 Sep; 80(17):3706-3718. PubMed ID: 32651259
[TBL] [Abstract] [Full Text] [Related]
15. De novo evolved gene product NCYM in the pathogenesis and clinical outcome of human neuroblastomas and other cancers.
Suenaga Y; Nakatani K; Nakagawara A
Jpn J Clin Oncol; 2020 Aug; 50(8):839-846. PubMed ID: 32577751
[TBL] [Abstract] [Full Text] [Related]
16. MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastoma.
Wei SJ; Nguyen TH; Yang IH; Mook DG; Makena MR; Verlekar D; Hindle A; Martinez GM; Yang S; Shimada H; Reynolds CP; Kang MH
Cell Death Dis; 2020 May; 11(5):368. PubMed ID: 32409685
[TBL] [Abstract] [Full Text] [Related]
17. Expression of GNAS, TP53, and PTEN Improves the Patient Prognostication in Sonic Hedgehog (SHH) Medulloblastoma Subgroup.
da Silva LS; Mançano BM; de Paula FE; Dos Reis MB; de Almeida GC; Matsushita M; Junior CA; Evangelista AF; Saggioro F; Serafini LN; Stavale JN; Malheiros SMF; Lima M; Hajj GNM; de Lima MA; Taylor MD; Leal LF; Reis RM
J Mol Diagn; 2020 Jul; 22(7):957-966. PubMed ID: 32380172
[TBL] [Abstract] [Full Text] [Related]
18. Nanotechnological based miRNA intervention in the therapeutic management of neuroblastoma.
Pottoo FH; Barkat MA; Harshita ; Ansari MA; Javed MN; Sajid Jamal QM; Kamal MA
Semin Cancer Biol; 2021 Feb; 69():100-108. PubMed ID: 31562954
[TBL] [Abstract] [Full Text] [Related]
19. mycn amplification drives an aggressive form of spinal ependymoma.
Ghasemi DR; Sill M; Okonechnikov K; Korshunov A; Yip S; Schutz PW; Scheie D; Kruse A; Harter PN; Kastelan M; Wagner M; Hartmann C; Benzel J; Maass KK; Khasraw M; Sträter R; Thomas C; Paulus W; Kratz CP; Witt H; Kawauchi D; Herold-Mende C; Sahm F; Brandner S; Kool M; Jones DTW; von Deimling A; Pfister SM; Reuss DE; Pajtler KW
Acta Neuropathol; 2019 Dec; 138(6):1075-1089. PubMed ID: 31414211
[TBL] [Abstract] [Full Text] [Related]
20. ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma.
Pieraccioli M; Nicolai S; Pitolli C; Agostini M; Antonov A; Malewicz M; Knight RA; Raschellà G; Melino G
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7356-7361. PubMed ID: 29941555
[TBL] [Abstract] [Full Text] [Related]
[Next]
